Quality of Life - the Primary Component in Senior Health Care

Sign Up

September 21st, 2014

Parkinson’s Drug Recall



Parkinson’s Drug Recall

September 4, 2014
Nearly 4,000 bottles of a Parkinson’s combination drug are being pulled from shelves, according to the U.S. Food and Drug Administration.

The U.S. nationwide recall is due to what may potentially be ‘superpotent’ carbidopa/levodopatablets.

This recall comes on the heels of a recall in April and June for the Israeli generic drug maker.



1. Teva Recalling ‘Superpotent’ Drug for Parkinson’s Disease. FDANews. 2014 Aug 27.

2. Palmer E. Teva recalls Parkinson's disease drug because it may be 'superpotent'. Fierce Pharma. 2014 Aug 26.

PLN Topics:
Medication Errors
Baxter Recalls Potassium Chloride Injection
Heparin Recall Due to Human Hair
Warfarin Sodium Tablets Recall
FDA Issues Reminder to Avoid Products from Texas Compounder
Compounding Pharmacy Recall

Geriatric Nutrition

Without good nutrition, positive drug therapy outcomes are very difficult to obtain, For the best in Geriatric Nutritional Information

Find out more Optima Solutions

Continuing Education

Each month we will post an analysis of specific aspects of government long-term healthcare regulations.

Find out more